Download PDF Info Publication number WO2019167070A1 WO2019167070A1 PCT/IN2019/050161 IN2019050161W WO2019167070A1 WO 2019167070 A1 WO2019167070 A1 WO 2019167070A1 IN 2019050161 W IN2019050161 W IN 2019050161W WO 2019167070 A1 WO2019167070 A1 WO 2019167070A1 Authority WO WIPO (PCT) Prior art keywords ghk hrs release transdermal transdermal composition Prior art date Legal status (The legal status is an assumption and is not a legal conclusion
Argireline and Leuphasyl are peptide compounds known for their wrinkle-smoothing properties
Step 6: Label the Bottle With Full Documentation At minimum, your label should include: the name of the compound, the concentration per actuation (in mcg per spray), the total volume in the bottle, the diluent used, and the date of reconstitution
Your doctor will let you know whats safe and effective for your health condition
Many bioactive compounds exhibit antioxidant, anti-inflammatory, hormone-modulating, and barrier-stabilizing properties, providing a biologically plausible foundation for nutritional interventions (Figure 2)
